One minute to ignite new thinking in COPD
- Article
- Campus Sanofi
- Apr 1, 2024
The article "How do different inflammatory pathways in COPD impact disease pathobiology and progression?" features insights from a round table discussion involving leading respiratory experts. It focuses on chronic obstructive pulmonary disease (COPD), a heterogeneous and progressive condition. The experts delved into the inflammatory processes in COPD, particularly type 2 pathway and its associated endotype, emphasizing the importance of identifying patients by endotypes.
The article "Current Unmet Needs for Patients with COPD" features insights from a round table discussion involving leading respiratory experts. It focuses on chronic obstructive pulmonary disease (COPD), a heterogeneous and progressive condition. The experts explore various aspects, such as the role of inflammatory pathways in disease progression, the importance of biomarkers in COPD management, and the significant global burden of COPD. The discussion also highlights the challenges in diagnosing COPD early, the impact of exacerbations on lung function and quality of life, and the need for more personalized treatment approaches .
This article highlights the stability and predictive value of blood eosinophil levels in COPD, showing their strong link to exacerbation risk. Consistently elevated eosinophil levels can guide personalized treatment, including early use of inhaled corticosteroids (ICS). Integrating eosinophil measurements into routine practice can improve long-term disease management and patient outcomes.